Stem-cell technology could give cattle breeders a new way to work with valuable genetics: researchers can grow bovine stem cells, make or screen genetic changes in culture, and investigate ways to use those cells to produce embryos or reproductive cells. A 2025 study reported gene-modified cows and sheep using a stem-cell-based method, but this remains a research pathway—not a routine breeding service with proven commercial gains.
What stem-cell technology adds to cattle breeding
Conventional cattle breeding selects animals with desirable traits and combines their existing genetic variation over generations. Genome editing is different: it changes targeted DNA, and it can be attempted through more than one route. Stem-cell-based breeding uses cultured cells as an intermediate platform for research, genetic editing or, potentially, embryo production. These approaches may be combined, but they are not interchangeable.
Bovine pluripotent stem cells can develop into multiple cell types. Researchers study several kinds, including bovine embryonic stem cells (bESCs), induced pluripotent stem cells (biPSCs) and expanded-potential stem cells (bEPSCs). In principle, a cultured cell population could be edited or screened before researchers attempt to use it in reproduction. That offers a way to study genetic changes before producing offspring, rather than relying only on editing an embryo and then assessing the resulting animal.
The central obstacle is biological as well as technical: establishing stable bovine pluripotent stem-cell lines in culture remains difficult. A 2024 review calls this “a critical scientific challenge.” Chen et al., “Bovine Pluripotent Stem Cells: Current Status and Prospects”
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →#1 Best Overall
How the approach might work
Grow and assess cells in culture
Researchers first need cell lines that can be maintained and characterized reliably. If those cells retain the properties needed for the intended use, they may provide a platform for studying development, testing genetic changes or attempting to generate reproductive cells. The outcome depends on the cell type and the method; the existence of a stem-cell line alone does not mean it can reliably produce a viable calf.
Edit or screen before attempting reproduction
One proposed advantage is to make or assess a chosen genetic change in cultured cells before using them in embryo-related procedures. Researchers could investigate edits associated with goals such as disease resistance or heat tolerance. Those are research aims, not established herd-wide results. The available reviews do not show that cultured-cell methods have delivered greater genetic gain, lower cost or better farm-level success than existing breeding practices.
Use cells in embryo research
Blastoids are organized, multicellular structures made from stem cells that mimic selected aspects of early embryo development. They are useful as models for studying development and are being explored as a possible component of “in vitro breeding.” They should not be treated as reliably transferable cattle embryos or as a commercial replacement for established embryo technologies. Practical challenges remain. Jiang, “Developing stem cell-based bovine embryos for in vitro breeding” (2026)
What researchers have demonstrated so far
A paper published in Nature Biotechnology on October 7, 2025, reported deriving haploid androgenetic embryonic stem cells from cows and sheep. The researchers used intracytoplasmic haploid embryonic stem-cell injection (iCHI), and reported that protamine expression helped create spermatid-like nuclei that improved full-term development of reconstructed embryos. The study also reported gene-modified cows and sheep after combining protamine-assisted iCHI with prime editing.
Recommended Free Tools
This is a significant research demonstration, but one study does not establish a repeatable commercial breeding system. It does not, by itself, establish producer access, costs, regulatory clearance, routine success rates or population-level improvement. The paper has a correction dated June 25, 2026; detailed experimental claims should be read against the corrected version. Yang et al., “Generation of modified cows and sheep from spermatid-like haploid embryonic stem cells”
How it compares with other routes to genetic improvement
Breeders and researchers can pursue genetic improvement through conventional selection, embryo editing or cultured-cell approaches. Each route raises different questions about where a change is made, whether it can be screened before offspring are produced, and how reliably the procedure leads to a healthy pregnancy. The available sources do not provide comparable commercial performance figures across all these methods, so they do not support a numerical ranking or a claim that stem-cell procedures are already superior.
| Approach | Where selection or change happens | Screening before offspring | Key evidence limit |
|---|---|---|---|
| Conventional selection | Breeding decisions use variation already present in the animals and their relatives. | Selection is based on available information about animals and their genetics; it does not create a targeted DNA edit. | The cited sources do not provide a comparable time, cost or genetic-gain figure. |
| Embryo genome editing | A targeted DNA change is made in a zygote or embryo. | Editing outcomes can be assessed, but embryo editing can involve mosaicism, in which not all cells carry the same edit. | The 2024 dairy genome-editing review discusses this trade-off but does not establish a universal success rate. Review |
| Somatic-cell nuclear transfer (SCNT) | A donor somatic cell is used in an embryo-reconstruction process. | Cells can be edited before reconstruction; the cited review notes this route can avoid embryo-editing mosaicism. | The same review notes potentially lower pregnancy rates; it does not provide a directly comparable commercial figure. |
| Stem-cell-based methods | Changes or screening may occur in cultured stem cells before embryo reconstruction or other reproductive steps. | Potentially allows cell-level editing or assessment before offspring production. | Stable bovine cell lines and reliable reproductive outcomes remain challenges; current sources do not establish superior efficiency, cost or genetic gain. |
Stem cells may eventually complement editing by making it possible to modify or screen cells before using them in reproduction. Reviews discuss the possibility of combining multiple edits, but whether that produces useful, safe and commercially viable cattle depends on both the biology and the breeding goal. The 2024 livestock embryonic stem-cell review described the field as relatively small and noted five reports of cattle embryonic stem cells available to that review; that is a count for its review context, not a current census. A separate 2024 review discusses commercial considerations for genome editing in dairy cattle, including target traits and evolving regulation. A June 2025 review of gene editing in cattle breeding also addresses the broader research context.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What would need to improve before farm use
Moving from promising experiments to a dependable breeding option would require more than producing a few gene-modified animals. The method would need to work reproducibly, fit existing cattle reproduction systems and demonstrate that its added complexity produces a useful outcome.
Best Value
- Reliable cell lines: stable bovine pluripotent cells must be established and maintained for the intended use.
- Reproductive performance: researchers need repeatable evidence that cell-based procedures can produce healthy offspring with predictable outcomes.
- Practical value: the approach must show a meaningful benefit for a defined breeding objective relative to available methods, with credible information about time and cost.
- Clear rules: applicable requirements will depend on the procedure, product and jurisdiction; there is no single global approval status for all gene-edited cattle.
Current sources do not establish a commercially available stem-cell cattle-breeding service or routine on-farm use. They also do not quantify its effect on pregnancy rates, productivity, genetic gain or cost.
What the U.S. FDA statement does—and does not—mean
The U.S. Food and Drug Administration defines animal cell and tissue products (ACTPs) as products containing, consisting of, or derived from cells or tissues intended for administration to an animal. Its information page states, “Currently, no ACTPs are FDA-approved.” That statement concerns ACTPs; it is not a blanket FDA ruling on gene-edited cattle breeding or a country-by-country account of livestock genome-editing rules. FDA, “Cell and Tissue Products for Animals” (accessed October 4, 2026)
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
